June 12th, 2025: EMA Links Semaglutide to Rare Vision Disorder The European Medicines Agency (EMA) has formally acknowledged a potential link between semaglutide, the key ingredient in Ozempic, Wegovy, and Rybelsus, and a rare but serious eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION)
Below is an example of some common household items and where they fall on the pH scale
To this end, WeightWatchers offers tons of recipes, the patented points system, fitness events led by coaches, unlimited 24/7 support with the care team, and private social media groups to offer encouragement
The higher the dose of Ozempic, the more extreme the effects
weight loss at target dose (trial data) ~21% (SURMOUNT) CV risk reduction labelled Under study Format Prefilled KwikPen + single-dose autoinjector India price (May 2026) 14,00027,500/month DCGI-approved Yes (March 2025) Generic competition in India No no Indian biosimilar yet Weight-loss percentages are trial averages at target dose individual response varies
Both patients can access semaglutide in Michigan